Our findings that participants with known diagnosis of liver steatosis have higher T1-FF than those without, and that T1-FF correlates with markers of liver health (ALT and GGT) provide evidence that the mDIXON approach is effective in identifying the target pathology. Here, GPT is linked to fatty liver disease.